Chevron Deference Overturned: What's Next for FDA's LDT Oversight

Haydar Celik, PhD

Published on: 02/07/2024

Explore how the Supreme Court's Chevron deference decision could reshape FDA oversight of laboratory developed tests (LDTs), regulatory authority, compliance strategies, and the future of diagnostic innovation.